Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

Nicholas G. Fisher, Jonathan P. Christiansen, Howard Leong-Poi, Ananda R. Jayaweera, Jonathan Lindner, Sanjiv Kaul

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

OBJECTIVES: This study sought to investigate the myocardial and microvascular kinetics of BR14, a novel third-generation ultrasound contrast agent. BACKGROUND: BR14 produces persistent myocardial opacification after the administration of a single intravenous bolus when the left ventricular cavity contrast has considerably diminished. The mechanism of this finding is unknown. METHODS: Nine open-chest dogs with non-critical stenosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyperemia. Time versus acoustic intensity (AI) plots were generated from the normal and stenosed beds and myocardial blood flow (MBF) was measured with radiolabeled microspheres. Intravital microscopy was performed on an exteriorized cremaster muscle in 11 wild-type mice to study the microvascular kinetics of the agent. RESULTS: At peak contrast enhancement, the ratio between AI in the stenosed and normal bed was 0.44 ± 0.23, which was similar to the radiolabeled microsphere-derived MBF ratio between the two beds (0.45 ± 0.20). At 400 s after injection, the AI ratio between the two beds approximated unity (0.99 ± 0.07) despite no changes in MBF, indicating redistribution of the agent. The myocardial kinetics of BR14 was best characterized by a modified lagged normal density function. Only about 3% of administered microbubbles were estimated to be retained in the myocardium. Intravital microscopy showed that most of these bubbles were retained only transiently (2 to 3 s) within capillaries. CONCLUSIONS: BR14 demonstrates redistribution because of transient retention within capillaries. Therefore, similar to 201Tl, it could potentially be used to detect both coronary stenosis and myocardial viability after a single injection during stress.

Original languageEnglish (US)
Pages (from-to)530-537
Number of pages8
JournalJournal of the American College of Cardiology
Volume39
Issue number3
DOIs
StatePublished - Feb 6 2002
Externally publishedYes

Fingerprint

Acoustics
Contrast Media
Microspheres
Abdominal Muscles
Microbubbles
Injections
Coronary Stenosis
Hyperemia
Intravenous Injections
Coronary Vessels
Myocardium
Pathologic Constriction
Thorax
Dogs
Intravital Microscopy

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. / Fisher, Nicholas G.; Christiansen, Jonathan P.; Leong-Poi, Howard; Jayaweera, Ananda R.; Lindner, Jonathan; Kaul, Sanjiv.

In: Journal of the American College of Cardiology, Vol. 39, No. 3, 06.02.2002, p. 530-537.

Research output: Contribution to journalArticle

Fisher, Nicholas G. ; Christiansen, Jonathan P. ; Leong-Poi, Howard ; Jayaweera, Ananda R. ; Lindner, Jonathan ; Kaul, Sanjiv. / Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. In: Journal of the American College of Cardiology. 2002 ; Vol. 39, No. 3. pp. 530-537.
@article{7e6348aa408a4be0a4fc65bdaabe1b2c,
title = "Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent",
abstract = "OBJECTIVES: This study sought to investigate the myocardial and microvascular kinetics of BR14, a novel third-generation ultrasound contrast agent. BACKGROUND: BR14 produces persistent myocardial opacification after the administration of a single intravenous bolus when the left ventricular cavity contrast has considerably diminished. The mechanism of this finding is unknown. METHODS: Nine open-chest dogs with non-critical stenosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyperemia. Time versus acoustic intensity (AI) plots were generated from the normal and stenosed beds and myocardial blood flow (MBF) was measured with radiolabeled microspheres. Intravital microscopy was performed on an exteriorized cremaster muscle in 11 wild-type mice to study the microvascular kinetics of the agent. RESULTS: At peak contrast enhancement, the ratio between AI in the stenosed and normal bed was 0.44 ± 0.23, which was similar to the radiolabeled microsphere-derived MBF ratio between the two beds (0.45 ± 0.20). At 400 s after injection, the AI ratio between the two beds approximated unity (0.99 ± 0.07) despite no changes in MBF, indicating redistribution of the agent. The myocardial kinetics of BR14 was best characterized by a modified lagged normal density function. Only about 3{\%} of administered microbubbles were estimated to be retained in the myocardium. Intravital microscopy showed that most of these bubbles were retained only transiently (2 to 3 s) within capillaries. CONCLUSIONS: BR14 demonstrates redistribution because of transient retention within capillaries. Therefore, similar to 201Tl, it could potentially be used to detect both coronary stenosis and myocardial viability after a single injection during stress.",
author = "Fisher, {Nicholas G.} and Christiansen, {Jonathan P.} and Howard Leong-Poi and Jayaweera, {Ananda R.} and Jonathan Lindner and Sanjiv Kaul",
year = "2002",
month = "2",
day = "6",
doi = "10.1016/S0735-1097(01)01759-4",
language = "English (US)",
volume = "39",
pages = "530--537",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent

AU - Fisher, Nicholas G.

AU - Christiansen, Jonathan P.

AU - Leong-Poi, Howard

AU - Jayaweera, Ananda R.

AU - Lindner, Jonathan

AU - Kaul, Sanjiv

PY - 2002/2/6

Y1 - 2002/2/6

N2 - OBJECTIVES: This study sought to investigate the myocardial and microvascular kinetics of BR14, a novel third-generation ultrasound contrast agent. BACKGROUND: BR14 produces persistent myocardial opacification after the administration of a single intravenous bolus when the left ventricular cavity contrast has considerably diminished. The mechanism of this finding is unknown. METHODS: Nine open-chest dogs with non-critical stenosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyperemia. Time versus acoustic intensity (AI) plots were generated from the normal and stenosed beds and myocardial blood flow (MBF) was measured with radiolabeled microspheres. Intravital microscopy was performed on an exteriorized cremaster muscle in 11 wild-type mice to study the microvascular kinetics of the agent. RESULTS: At peak contrast enhancement, the ratio between AI in the stenosed and normal bed was 0.44 ± 0.23, which was similar to the radiolabeled microsphere-derived MBF ratio between the two beds (0.45 ± 0.20). At 400 s after injection, the AI ratio between the two beds approximated unity (0.99 ± 0.07) despite no changes in MBF, indicating redistribution of the agent. The myocardial kinetics of BR14 was best characterized by a modified lagged normal density function. Only about 3% of administered microbubbles were estimated to be retained in the myocardium. Intravital microscopy showed that most of these bubbles were retained only transiently (2 to 3 s) within capillaries. CONCLUSIONS: BR14 demonstrates redistribution because of transient retention within capillaries. Therefore, similar to 201Tl, it could potentially be used to detect both coronary stenosis and myocardial viability after a single injection during stress.

AB - OBJECTIVES: This study sought to investigate the myocardial and microvascular kinetics of BR14, a novel third-generation ultrasound contrast agent. BACKGROUND: BR14 produces persistent myocardial opacification after the administration of a single intravenous bolus when the left ventricular cavity contrast has considerably diminished. The mechanism of this finding is unknown. METHODS: Nine open-chest dogs with non-critical stenosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyperemia. Time versus acoustic intensity (AI) plots were generated from the normal and stenosed beds and myocardial blood flow (MBF) was measured with radiolabeled microspheres. Intravital microscopy was performed on an exteriorized cremaster muscle in 11 wild-type mice to study the microvascular kinetics of the agent. RESULTS: At peak contrast enhancement, the ratio between AI in the stenosed and normal bed was 0.44 ± 0.23, which was similar to the radiolabeled microsphere-derived MBF ratio between the two beds (0.45 ± 0.20). At 400 s after injection, the AI ratio between the two beds approximated unity (0.99 ± 0.07) despite no changes in MBF, indicating redistribution of the agent. The myocardial kinetics of BR14 was best characterized by a modified lagged normal density function. Only about 3% of administered microbubbles were estimated to be retained in the myocardium. Intravital microscopy showed that most of these bubbles were retained only transiently (2 to 3 s) within capillaries. CONCLUSIONS: BR14 demonstrates redistribution because of transient retention within capillaries. Therefore, similar to 201Tl, it could potentially be used to detect both coronary stenosis and myocardial viability after a single injection during stress.

UR - http://www.scopus.com/inward/record.url?scp=0037028596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037028596&partnerID=8YFLogxK

U2 - 10.1016/S0735-1097(01)01759-4

DO - 10.1016/S0735-1097(01)01759-4

M3 - Article

VL - 39

SP - 530

EP - 537

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 3

ER -